Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

Approval Number

国药准字H20253160

Company北京福元医药股份有限公司

Registration Date

January 14, 2025

Drug Information

Generic Name

达格列净二甲双胍缓释片(Ⅰ)

Dosage Form

片剂

Strength

达格列净10mg（以C₂₁H₂₅ClO₆计）和盐酸二甲双胍1000mg

Drug Type

化学药品

Registration Date

January 14, 2025

Company Information

Applicant Company

Company Name北京福元医药股份有限公司

Company Address

北京市通州区通州工业开发区广源东街8号

Manufacturing Company

Company Name北京福元医药股份有限公司

Company Address

北京市通州区通州工业开发区广源东街8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy